Glance

Glance vs Neurons

Compare cost, data handling and evidence before choosing an attention tool.

Glance is in development. Neurons is compared using the linked vendor pages, reviewed 11 November 2026. Unknown fields stay marked; this is not a hands-on performance comparison.

What is established, and what still needs checking
DecisionGlanceNeurons
PriceFree; own code MIT.Quote-based Starter, Pro and Scale packages; no numeric price on reviewed pricing page.
Offline / privacyDesigned for local inference after model download; clients have separate privacy boundaries.Predict is described as cloud-based; verify retention and enterprise deployment terms.
Open modelsSUM / TranSalNet MIT code; UNISAL Apache-2.0 code per SPEC. Asset rights and export readiness pending.Redistributable model weights not established by reviewed pages.
Published accuracy methodFormulas documented; no Glance benchmark claim. DeepGaze IIE reference results are not Glance results.Vendor advertises +95% prediction accuracy. Dataset, raw metric and denominator for direct comparison: TODO-verify.

Sources: Neurons pricing or commercial terms · Neurons product or accuracy statement. Vendor claims are attributed, not independently validated here. Plan details may change.

Which workflow fits?

Choose Neurons when its hosted creative testing and customer support meet your needs. Consider Glance’s planned local workflow for independent design checks.

Compare the same assets under the same viewing conditions. Ask for raw saliency metrics on a named dataset before treating vendor percentages as comparable.

Questions before you start

Is Glance a free Neurons alternative?

Glance is intended as a free, open-source desktop attention prediction alternative. It is in development; confirm release availability and the features your workflow needs.

Which tool is more accurate?

No direct comparison is established here. Compare the same dataset, metric, viewing protocol and preprocessing before ranking model performance.

Choose your next check